Holland Capital invests in Medexs and Van Vliet Healthcare, two renowned companies that support hospitals and clinics with a wide range of technological expertise, products, and services.

Our portfolio company Relay42, a leading real-time Customer Data Platform (CDP), has been acquired by Supermetrics, the leading Marketing Intelligence Platform. Holland Capital actively supported Relay42 in both operational and strategic development since becoming a shareholder in 2015.

Our portfolio company The Storytelling Company adds the award-winning Berlin-based visual design studio flora&faunavisions to its portfolio of groundbreaking businesses

This year, a group of sporty colleagues from Holland Capital are taking on a heroic challenge: the Marmotte – one of the toughest and most iconic cycling tours in the French Alps.

Last week, in partnership with Deloitte, we hosted an engaging and inspiring ESG webinar for our portfolio companies.

Investment firm Holland Capital is investing in Gullimex, a strong player in measurement, quality, and control solutions within the food and medical sectors. Holland Capital’s investment provides Gullimex the opportunity to realize its growth ambitions.

Our portfolio company Sirius Medical, the innovator of Surgical Marker Navigation and Mammotome, a globally recognized leader in breast care, are proud to announce an exclusive distribution agreement for the United States and Germany.

Our portfolio company Sirius Medical, a leading medtech company and market leader in oncological surgical marker navigation, has raised €10 million in funding on World Cancer Day.